Literature DB >> 11044912

Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production.

G Schiedner1, S Hertel, S Kochanek.   

Abstract

Primary human cells are relatively refractory to transformation by adenoviral E1 functions. For almost two decades, human embryonic kidney (HEK)-derived 293 cells have been the only E1-complementing cell line suitable for production of E1-deleted adenoviral vectors. More recently, new vector production cell lines have been derived from human embryonic retina (HER) cells, a cell type that is difficult to obtain. We were surprised to find that readily available primary human amniocytes are efficiently transformed by adenoviral E1 functions. We selected cell lines that allow high-titer production of recombinant adenoviral vectors. The generation of replication-competent adenovirus (RCA) during production, caused by homologous recombination between vector and cellular DNA, was excluded by designing the transforming plasmid to lack sequence overlap with current adenoviral vectors. In addition, we generated an infectious plasmid that can be used for convenient generation of first-generation adenoviral vectors in Escherichia coli and that matches the E1 complementation in the new production cell lines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044912     DOI: 10.1089/104303400750001417

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  61 in total

1.  Long-term transgene expression in proliferating cells mediated by episomally maintained high-capacity adenovirus vectors.

Authors:  Florian Kreppel; Stefan Kochanek
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

2.  Minimal cis-acting elements required for adenovirus genome packaging.

Authors:  Philomena Ostapchuk; Patrick Hearing
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  The L4 22-kilodalton protein plays a role in packaging of the adenovirus genome.

Authors:  Philomena Ostapchuk; Mary E Anderson; Sharanya Chandrasekhar; Patrick Hearing
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Role for the L1-52/55K protein in the serotype specificity of adenovirus DNA packaging.

Authors:  Beverly P Wohl; Patrick Hearing
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

5.  A new complementing cell line for replication-incompetent E1-deleted adenovirus propagation.

Authors:  Qingfu Xu; Maria T Arevalo; Michael E Pichichero; Mingtao Zeng
Journal:  Cytotechnology       Date:  2006-11-18       Impact factor: 2.058

6.  Cell culture processes for the production of viral vectors for gene therapy purposes.

Authors:  James N Warnock; Otto-Wilhelm Merten; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2006-06-30       Impact factor: 2.058

7.  Robust hepatic gene silencing for functional studies using helper-dependent adenoviral vectors.

Authors:  Rafaela Ruiz; Scott R Witting; Romil Saxena; Núria Morral
Journal:  Hum Gene Ther       Date:  2009-01       Impact factor: 5.695

8.  miRNA-mediated silencing in hepatocytes can increase adaptive immune responses to adenovirus vector-delivered transgenic antigens.

Authors:  Matthias W Kron; Sigrid Espenlaub; Tatjana Engler; Reinhold Schirmbeck; Stefan Kochanek; Florian Kreppel
Journal:  Mol Ther       Date:  2011-05-10       Impact factor: 11.454

9.  Transient pretreatment with glucocorticoid ablates innate toxicity of systemically delivered adenoviral vectors without reducing efficacy.

Authors:  Sergey S Seregin; Daniel M Appledorn; Aaron J McBride; Nathaniel J Schuldt; Yasser A Aldhamen; Tyler Voss; Junping Wei; Matthew Bujold; William Nance; Sarah Godbehere; Andrea Amalfitano
Journal:  Mol Ther       Date:  2009-01-27       Impact factor: 11.454

10.  A molecular tweezer antagonizes seminal amyloids and HIV infection.

Authors:  Edina Lump; Laura M Castellano; Christoph Meier; Janine Seeliger; Nelli Erwin; Benjamin Sperlich; Christina M Stürzel; Shariq Usmani; Rebecca M Hammond; Jens von Einem; Gisa Gerold; Florian Kreppel; Kenny Bravo-Rodriguez; Thomas Pietschmann; Veronica M Holmes; David Palesch; Onofrio Zirafi; Drew Weissman; Andrea Sowislok; Burkhard Wettig; Christian Heid; Frank Kirchhoff; Tanja Weil; Frank-Gerrit Klärner; Thomas Schrader; Gal Bitan; Elsa Sanchez-Garcia; Roland Winter; James Shorter; Jan Münch
Journal:  Elife       Date:  2015-08-18       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.